Evaluation of DFO-HOPO as an octadentate chelator for zirconium-89

被引:39
作者
Allott, L. [1 ]
Da Pieve, C. [1 ]
Meyers, J. [2 ]
Spinks, T. [1 ]
Ciobota, D. M. [1 ]
Kramer-Marek, G. [1 ]
Smith, G. [1 ]
机构
[1] Inst Canc Res, Div Radiotherapy & Imaging, 123 Old Brompton Rd, London, England
[2] Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, 123 Old Brompton Rd, London, England
基金
英国惠康基金;
关键词
POSITRON-EMISSION-TOMOGRAPHY; MONOCLONAL-ANTIBODIES; HYDROXAMATE LIGANDS; ZR-89; RADIOCHEMISTRY;
D O I
10.1039/c7cc03572a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The future of Zr-89-based immuno-PET is reliant upon the development of new chelators with improved stability compared to the currently used deferoxamine (DFO). Herein, we report the evaluation of the octadentate molecule DFO-HOPO (3) as a suitable chelator for Zr-89 and a more stable alternative to DFO. The molecule showed good potential for the future development of a DFO-HOPO-based bifunctional chelator (BFC) for the radiolabelling of biomolecules with Zr-89. This work broadens the selection of available chelators for Zr-89 in search of improved successors to DFO for clinical Zr-89-immuno-PET.
引用
收藏
页码:8529 / 8532
页数:4
相关论文
共 20 条
[1]   Macrocycle-Based Hydroxamate Ligands for Complexation and Immunoconjugation of 89Zirconium for Positron Emission Tomography (PET) Imaging [J].
Boros, Eszter ;
Holland, Jason P. ;
Kenton, Nathaniel ;
Rotile, Nicholas ;
Caravan, Peter .
CHEMPLUSCHEM, 2016, 81 (03) :274-281
[2]   Alternative Chelator for 89Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO) [J].
Deri, Melissa A. ;
Ponnala, Shashikanth ;
Zeglis, Brian M. ;
Pohl, Gabor ;
Dannenberg, J. J. ;
Lewis, Jason S. ;
Francesconi, Lynn C. .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) :4849-4860
[3]   PET imaging with 89Zr: From radiochemistry to the clinic [J].
Deri, Melissa A. ;
Zeglis, Brian M. ;
Francesconi, Lynn C. ;
Lewis, Jason S. .
NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (01) :3-14
[4]   89Zr, a Radiometal Nuclide with High Potential for Molecular Imaging with PET: Chemistry, Applications and Remaining Challenges [J].
Fischer, Gabriel ;
Seibold, Uwe ;
Schirrmacher, Ralf ;
Waengler, Bjoern ;
Waengler, Carmen .
MOLECULES, 2013, 18 (06) :6469-6490
[5]   Rational Design, Synthesis, and Evaluation of Tetrahydroxamic Acid Chelators for Stable Complexation of Zirconium( IV) [J].
Guerard, Francois ;
Lee, Yong-Sok ;
Brechbiel, Martin W. .
CHEMISTRY-A EUROPEAN JOURNAL, 2014, 20 (19) :5584-5591
[6]   Charting the mechanism and reactivity of zirconium oxalate with hydroxamate ligands using density functional theory: implications in new chelate design [J].
Holland, Jason P. ;
Vasdev, Neil .
DALTON TRANSACTIONS, 2014, 43 (26) :9872-9884
[7]   89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo [J].
Holland, Jason P. ;
Divilov, Vadim ;
Bander, Neil H. ;
Smith-Jones, Peter M. ;
Larson, Steven M. ;
Lewis, Jason S. .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (08) :1293-1300
[8]   Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials? [J].
Jauw, Yvonne W. S. ;
Menke-van der Houven van Oordt, C. Willemien ;
Hoekstra, Otto S. ;
Hendrikse, N. Harry ;
Vugts, Danielle J. ;
Zijlstra, Josee M. ;
Huisman, Marc C. ;
van Dongen, Guus A. M. S. .
FRONTIERS IN PHARMACOLOGY, 2016, 7
[9]   Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with 89Zr4+: comparison with desferrioxamine-B [J].
Ma, Michelle T. ;
Meszaros, Levente K. ;
Paterson, Brett M. ;
Berry, David J. ;
Cooper, Maggie S. ;
Ma, Yongmin ;
Hiderd, Robert C. ;
Blower, Philip J. .
DALTON TRANSACTIONS, 2015, 44 (11) :4884-4900
[10]   Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development [J].
Pandya, Darpan N. ;
Bhatt, Nikunj ;
Yuan, Hong ;
Day, Cynthia S. ;
Ehrmann, Brandie M. ;
Wright, Marcus ;
Bierbach, Ulrich ;
Wadas, Thaddeus J. .
CHEMICAL SCIENCE, 2017, 8 (03) :2309-2314